BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 29254328)

  • 1. Role of biomarkers in adult sepsis and their application for a good laboratory practice: a pilot study.
    Sargentini V; Collepardo D; D Alessandro M; Petralito G; Ceccarelli G; Alessandri F; Piciocchi A; Angeloni A; Venditti M; Bachetoni A
    J Biol Regul Homeost Agents; 2017; 31(4):1147-1154. PubMed ID: 29254328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The study on pro-adrenomedullin as a new biomarker in sepsis prognosis and risk stratification].
    Kang FX; Wang RL; Yu KL; Wei Q
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Aug; 20(8):452-5. PubMed ID: 18687169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of pro-adrenomedullin in early diagnosis of sepsis].
    Yan L; Cailan L; Hong L; Zheng L; Wei D
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Sep; 27(9):739-42. PubMed ID: 26955700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin.
    Enguix-Armada A; Escobar-Conesa R; García-De La Torre A; De La Torre-Prados MV
    Clin Chem Lab Med; 2016 Jan; 54(1):163-8. PubMed ID: 26083268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment.
    Behnes M; Bertsch T; Lepiorz D; Lang S; Trinkmann F; Brueckmann M; Borggrefe M; Hoffmann U
    Crit Care; 2014 Sep; 18(5):507. PubMed ID: 25190134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presepsin versus other biomarkers to predict sepsis and septic shock in patients with infection defined by Sepsis-3 criteria: the PREDI study of diagnostic accuracy.
    Contenti J; Occelli C; Lemoel F; Ferrari P; Levraut J
    Emergencias; 2019 Oct; 31(5):311-317. PubMed ID: 31625302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CD14 Subtype-A New Biomarker in Predicting the Outcome of Critically Ill Septic Patients.
    Matera G; Quirino A; Peronace C; Settembre P; Marano V; Loria MT; Marascio N; Galati L; Barreca GS; Giancotti A; Amantea B; Liberto MC; Focà A
    Am J Med Sci; 2017 Jun; 353(6):543-551. PubMed ID: 28641717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic role of procalcitonin (PCT) and MR-pro-Adrenomedullin (MR-proADM) in bacterial infections.
    Angeletti S; Spoto S; Fogolari M; Cortigiani M; Fioravanti M; De Florio L; Curcio B; Cavalieri D; Costantino S; Dicuonzo G
    APMIS; 2015 Sep; 123(9):740-8. PubMed ID: 26058482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial.
    Masson S; Caironi P; Spanuth E; Thomae R; Panigada M; Sangiorgi G; Fumagalli R; Mauri T; Isgrò S; Fanizza C; Romero M; Tognoni G; Latini R; Gattinoni L;
    Crit Care; 2014 Jan; 18(1):R6. PubMed ID: 24393424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study.
    Ulla M; Pizzolato E; Lucchiari M; Loiacono M; Soardo F; Forno D; Morello F; Lupia E; Moiraghi C; Mengozzi G; Battista S
    Crit Care; 2013 Jul; 17(4):R168. PubMed ID: 23899120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia.
    España PP; Capelastegui A; Mar C; Bilbao A; Quintana JM; Diez R; Esteban C; Bereciartua E; Unanue U; Uranga A
    J Infect; 2015 May; 70(5):457-66. PubMed ID: 25499199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic value of lipopolysaccharide binding protein and procalcitonin in patients with severe sepsis and septic shock admitted to intensive care].
    García de Guadiana-Romualdo LM; Rebollo-Acebes S; Esteban-Torrella P; Jiménez-Sánchez R; Hernando-Holgado A; Ortín-Freire A; Viqueira-González M; Trujillo-Santos J; Jiménez Santos E; Pedregosa Díaz J; Albaladejo-Otón MD; Allegue-Gallego JM
    Med Intensiva; 2015 May; 39(4):207-12. PubMed ID: 24953001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of presepsin (sCD14-ST) as a biomarker of infection and sepsis in the emergency department.
    de Guadiana Romualdo LG; Torrella PE; Acebes SR; Otón MDA; Sánchez RJ; Holgado AH; Santos EJ; Freire AO
    Clin Chim Acta; 2017 Jan; 464():6-11. PubMed ID: 27823951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic value of procalcitonin and mid-regional pro-adrenomedullin in septic paediatric patients.
    Solé-Ribalta A; Bobillo-Pérez S; Valls A; Girona-Alarcón M; Launes C; Cambra FJ; Jordan I; Esteban E
    Eur J Pediatr; 2020 Jul; 179(7):1089-1096. PubMed ID: 31974673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean population.
    Kweon OJ; Choi JH; Park SK; Park AJ
    J Crit Care; 2014 Dec; 29(6):965-70. PubMed ID: 25042676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic value of sCD14-ST--presepsin for patients admitted to hospital intensive care unit (ICU).
    Godnic M; Stubljar D; Skvarc M; Jukic T
    Wien Klin Wochenschr; 2015 Jul; 127(13-14):521-7. PubMed ID: 25854904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction about severity and outcome of sepsis by pro-atrial natriuretic peptide and pro-adrenomedullin.
    Wang RL; Kang FX
    Chin J Traumatol; 2010 Jun; 13(3):152-7. PubMed ID: 20515592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of adrenomedullin in septic patients in the ED.
    Chen YX; Li CS
    Am J Emerg Med; 2013 Jul; 31(7):1017-21. PubMed ID: 23688561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of presepsin as diagnostic and prognostic marker of sepsis in daily clinical practice.
    Jereb M; Mavric M; Skvarc M; Drobnic A; Dolenc S; Strunjas NP; Luksic B; Kmet NG
    J Infect Dev Ctries; 2019 Nov; 13(11):1038-1044. PubMed ID: 32087076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission.
    Suberviola B; Castellanos-Ortega A; Ruiz Ruiz A; Lopez-Hoyos M; Santibañez M
    Intensive Care Med; 2013 Nov; 39(11):1945-52. PubMed ID: 23949703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.